Purchases and Sales Made in Q2 2023 in Unicycive Therapeutics, Inc. (UNCY)
This table provides information about the institutional ownership of Unicycive Therapeutics, Inc. (UNCY) during Q2 2023. The information is specifically focused on institutions that hold shares of Unicycive Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
95.9KNew |
$119K - $214K
|
95.9K
$77.7K
|
|
|
Aug 10, 2023
Q2 2023
|
Ground Swell Capital, LLC
Folly Beach, SC |
BUY
|
- |
20KNew |
$24.8K - $44.6K
|
20K
$16.2K
|
|
|
Aug 14, 2023
Q2 2023
|
Centiva Capital, LP
New York, NY |
BUY
|
- |
15.2KNew |
$18.8K - $33.9K
|
15.2K
$12.3K
|
|
|
Aug 14, 2023
Q2 2023
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
14.5KNew |
$17.9K - $32.2K
|
14.5K
$11.7K
|
|
|
May 14, 2024
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
2.59K+ 2.77% |
$3.21K - $5.77K
|
95.9K
$77.7K
|
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
BUY
|
- |
1.17KNew |
$1.45K - $2.61K
|
1.17K
$947
|
|
|
Aug 14, 2023
Q2 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
600+ 4.11% |
$744 - $1.34K
|
15.2K
$12.3K
|
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
2+ 4.26% |
$2.48 - $4.46
|
49
$39.7
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.35K- 39.54% |
$1.68K - $3.01K
|
2.07K
$1.67K
|
|
|
Aug 11, 2023
Q2 2023
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-29.1K- 30.39% |
$36.1K - $65K
|
66.8K
$54.1K
|